Press Releases
PANTHERx® Rare Introduces New Capabilities to Support Cell and Gene Therapies
April 2, 2025
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce the launch of RxARECONCIERGE™, a new patient support model to improve access, logistics, and coordination of...
Read MorePANTHERx® Rare Selected by Soleno Therapeutics for the Distribution of VYKAT™ XR
March 27, 2025
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Soleno Therapeutics as the specialty pharmacy for the distribution of VYKAT™ XR (diazoxide...
Read MorePANTHERx® Rare Selected by Upsher-Smith Laboratories, LLC as Specialty Pharmacy for VIGAFYDE™ (vigabatrin) Oral Solution
March 24, 2025
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Upsher-Smith for the distribution of VIGAFYDE™ (vigabatrin), a ready-to-use, concentrated...
Read MorePANTHERx® Rare Named to USA Today’s List of Top Workplaces for 2025
March 20, 2025
PITTSBURGH – PANTHERx® Rare, one of the nation’s largest and fastest growing rare disease specialty pharmacies, announced today that it has been recognized as one of the Top Places to Work by USA Today. This prestigious recognition highlights...
Read MorePANTHERx® Rare Selected by Ionis as Specialty Pharmacy for TRYNGOLZA™ (olezarsen)
December 23, 2024
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Ionis Pharmaceuticals, Inc. for the distribution of TRYNGOLZA™ (olezarsen), the first...
Read MoreNeurocrine Biosciences, Inc. Selects PANTHERx® Rare Specialty Pharmacy for Distribution of Crenessity™ (crinecerfont)
December 20, 2024
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Neurocrine Biosciences, Inc. for the distribution of CRENESSITY™ (crinecerfont), an...
Read MoreNo posts found